<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00587002</url>
  </required_header>
  <id_info>
    <org_study_id>07-001023</org_study_id>
    <secondary_id>Epi-Plaque</secondary_id>
    <nct_id>NCT00587002</nct_id>
  </id_info>
  <brief_title>Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction</brief_title>
  <official_title>Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The broad objective is to advance our understanding of both in vivo anatomical and functional&#xD;
      changes that are present in the coronary arteries in women who have an acute coronary&#xD;
      syndrome. Specific focus will be placed on the age of the women as there may be distinct&#xD;
      differences in younger women (&lt; 50 years) given the marked increase in mortality in this&#xD;
      population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis of the current study is that plaque erosion and microvascular dysfunction are&#xD;
      key features responsible for the increased peri-MI mortality in young women. In order to test&#xD;
      this hypothesis the following specific aims are proposed using a special intravascular&#xD;
      ultrasound technique called virtual histology and microvascular function (effect of&#xD;
      intracoronary adenosine on coronary blood flow) in patients coming to the cardiac&#xD;
      catheterization laboratory with an acute MI:&#xD;
&#xD;
        1. To determine if plaque rupture or plaque erosion is more prevalent in young women (&lt;50&#xD;
           years) compared with older women (≥ 50 years) and men in the development of an acute MI&#xD;
&#xD;
        2. To determine if inflammatory mediators of plaque rupture are higher in older women and&#xD;
           men with an acute MI compared with younger women&#xD;
&#xD;
        3. To determine if microvascular function is abnormal in young women undergoing&#xD;
           percutaneous coronary revascularization with an acute MI compared to older women and men&#xD;
&#xD;
        4. To determine if alterations exist in the number and function of EPCs in young women (&lt;50&#xD;
           years) compared with older women (≥ 50 years) and men who have had an acute MI and to&#xD;
           determine the association with microvascular function&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plaque Virtual Histology</measure>
    <time_frame>Performed during PCI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial Progenitor Cells</measure>
    <time_frame>Collected immediately pre PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microvascular function in the noninfarct related vessel</measure>
    <time_frame>Assessed immediately post PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Virtual Histology in noninfarct related vessel</measure>
    <time_frame>Assessed immediately post PCI</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gender comparison</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVUS</intervention_name>
    <description>Intravascular ultrasound with virtual histology</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of 18 years or older&#xD;
&#xD;
          -  Acute coronary syndrome defined as at least two of the following:&#xD;
&#xD;
        A) an elevated cardiac biomarker (troponin or CK-MB), B) new or dynamic ECG changes in at&#xD;
        least 2 contiguous standard electrocardiographic leads of ST depression &gt; 1 mm or ST&#xD;
        elevation of &gt;1 mm or T-wave inversions, C) chest pain or discomfort of at least 15 minutes&#xD;
        duration, D) a new wall motion abnormality by echocardiography&#xD;
&#xD;
          -  Patient who is undergoing coronary angiography&#xD;
&#xD;
          -  Physician planning to perform IVUS for treatment of the infarct-related vessel&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Creatinine &gt; 2.0 mg/dL (most recent)&#xD;
&#xD;
          -  Hemodynamically unstable patients (systolic blood pressure &lt; 90 mmHg or heart rate &gt;&#xD;
             110 beats/ minute or presence of an intra-aortic balloon pump)&#xD;
&#xD;
          -  Coronary revascularization (percutaneously or surgically) within 6 months&#xD;
&#xD;
          -  The use of chronic immunosuppressive agents&#xD;
&#xD;
          -  No target lesion was found at the time of cardiac catheterization that will be&#xD;
             percutaneously intervened upon (the patient must undergo percutaneous coronary&#xD;
             intervention)&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia M. Best, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.mayo.edu</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2011</verification_date>
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2008</study_first_posted>
  <last_update_submitted>April 13, 2011</last_update_submitted>
  <last_update_submitted_qc>April 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Patricia Best, M.D.</name_title>
    <organization>Mayo Clinic</organization>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

